| Literature DB >> 32626771 |
Jianqing Li1, Xue Yin1, Bingyu Zhang1, Chen Li1, Peirong Lu1.
Abstract
PURPOSE: Macrophage aging is involved with the occurrence and progression of age-related macular degeneration (AMD). The purpose of this study was to identify the specific microRNAs (miRNA), mRNAs, and their interactions underlying macrophage aging and response to cholesterol through bioinformatical analysis in order to get a better understanding of the mechanism of AMD.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32626771 PMCID: PMC7306864 DOI: 10.1155/2020/9267475
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Differentially expressed miRNAs and mRNAs in macrophage aging. The volcano plot (a) and the heat map (b) showed that a total of 14 miRNAs were detected to be differentially expressed; 7 were upregulated and 7 downregulated. The volcano plot (c) and the heat map (d) displayed that 101 miRNAs expressed differentially between aged and young macrophages, and 7 of them were upregulated.
Figure 2miRNA-mRNA interactions underlying macrophage aging. miRNA-mRNA interaction analysis was conducted on the differentially expressed miRNAs and mRNAs in macrophage aging and 19 validated (a) and 544 predicted pairs (b) were identified. In addition, 83 highly predicted miRNA-mRNA pairs (c) were found which could be detected by four prediction databases.
The top 9 Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways of the differentially expressed miRNAs targets between aged and young macrophages.
| Category | GO term | Description | Count | Genes | |
|---|---|---|---|---|---|
| BP | GO:0006955 | Immune response | 16 | CCL24, CCL2, CXCR5, CXCL5, ENPP2, PRG4, CXCL13, H2-OB, MCPT4, CCL8, CMA1, TGTP2, CCL5, LTB, CCL7, BMPR1A | |
| GO:0006954 | Inflammatory response | 10 | CCL24, SELP, CCL2, CXCL5, CXCL13, EPHX2, CCL8, CD5L, CCL5, CCL7 | ||
| GO:0006935 | Chemotaxis | 9 | CCL24, CCL2, CXCR5, CXCL5, CXCL13, ENPP2, CCL8, CCL5, CCL7 | ||
| GO:0045766 | Positive regulation of angiogenesis | 8 | CCL24, PTGIS, CYP1B1, LRG1, SFRP2, HSPB1, CMA1, CCL5 | ||
| GO:0055114 | Oxidation-reduction process | 8 | CYP7B1, PTGIS, CYP1B1, SCD2, MAOA, CH25H, CP, DHCR24 | ||
| GO:0070098 | Chemokine-mediated signaling pathway | 7 | CCL24, CCL2, CXCL5, CXCL13, CCL8, CCL5, CCL7 | ||
| GO:0071347 | Cellular response to interleukin-1 | 7 | LCN2, CCL24, CCL2, PTGIS, CCL8, CCL5, CCL7 | ||
| GO:0006629 | Lipid metabolic process∗ | 7 | CYP7B1, PTGIS, SCD2, ENPP2, CH25H, EPHX2, DHCR24 | ||
| GO:0008284 | Positive regulation of cell proliferation | 7 | PRL2C3, CCND2, ENPP2, SFRP2, MZB1, PLAC8, TIMP1 | ||
|
| |||||
| MF | GO:0005125 | Cytokine activity | 10 | CCL24, CCL2, CXCR5, CXCL5, ENPP2, PRG4, CXCL13, H2-OB, MCPT4, CCL8, CMA1, TGTP2, CCL5, LTB, CCL7, BMPR1A | |
| GO:0008009 | Chemokine activity | 7 | CCL24, SELP, CCL2, CXCL5, CXCL13, EPHX2, CCL8, CD5L, CCL5, CCL7 | ||
| GO:0005525 | GTP binding | 7 | CCL24, CCL2, CXCR5, CXCL5, CXCL13, ENPP2, CCL8, CCL5, CCL7 | ||
| GO:0016491 | Oxidoreductase activity | 7 | CCL24, PTGIS, CYP1B1, LRG1, SFRP2, HSPB1, CMA1, CCL5 | ||
| GO:0042803 | Protein homodimerization activity | 7 | CYP7B1, PTGIS, CYP1B1, SCD2, MAOA, CH25H, CP, DHCR24 | ||
| GO:0008201 | Heparin binding | 6 | CCL24, CCL2, CXCL5, CXCL13, CCL8, CCL5, CCL7 | ||
| GO:0005506 | Iron ion binding | 6 | LCN2, CCL24, CCL2, PTGIS, CCL8, CCL5, CCL7 | ||
| GO:0004497 | Monooxygenase activity | 4 | CYP7B1, PTGIS, SCD2, ENPP2, CH25H, EPHX2, DHCR24 | ||
| GO:0030414 | Peptidase inhibitor activity | 4 | PRL2C3, CCND2, ENPP2, SFRP2, MZB1, PLAC8, TIMP1 | ||
|
| |||||
| CC | GO:0005615 | Extracellular space | 29 | GDF3, CCL2, CXCL5, ENPP2, LUM, IGFBP7, SERPINB1A, CCL8, CCL5, MMP3, CCL7, TIMP1, PRL2C3, CCL24, PTGIS, LRG1, MS4A1, CPA3, LTB, SELP, ACTA2, PRG4, SERPING1, LCN2, CXCL13, SFRP2, SERPINB2, HSPB1, CP | |
| GO:0005576 | Extracellular region | 25 | GDF3, CCL2, CXCL5, ENPP2, LUM, IGFBP7, CCL8, CCL5, MMP3, CCL7, TIMP1, CCL24, PRL2C3, PRG4, MZB1, SERPING1, CD5L, LCN2, BGN, PENK, CXCL13, SFRP2, SERPINB2, CMA1, CP | ||
| GO:0070062 | Extracellular exosome | 21 | CPNE8, ACTA2, LUM, IGFBP7, EPHX2, SERPINB1A, SERPING1, CD5L, TIMP1, LCN2, CD38, CD55, ASPA, CD19, BGN, LRG1, MS4A1, HSPB1, CD79B, CP, VSIG4 | ||
| GO:0009897 | External side of plasma membrane | 11 | LY6A, FCER1A, LY6C1, SELP, CD55, CD19, CXCR5, MS4A1, CD79B, CD79A, BMPR1A | ||
| GO:0005789 | Endoplasmic reticulum membrane | 8 | CYP7B1, PTGIS, CYP1B1, SCD2, CH25H, TGTP2, DHCR24, GIMAP1 | ||
| GO:0031012 | Extracellular matrix | 7 | BGN, LUM, IGFBP7, HSPB1, CMA1, MMP3, TIMP1 | ||
| GO:0031225 | Anchored component of membrane | 4 | LY6A, LY6C1, CD55, LY6D | ||
| GO:0031090 | Organelle membrane | 3 | CYP7B1, CYP1B1, SCD2 | ||
| GO:0019815 | B cell receptor complex | 2 | CD79B, CD79A | ||
|
| |||||
| KEGG pathways | mmu04060 | Cytokine-cytokine receptor interaction | 10 | CCL24, CCL2, CXCR5, CXCL5, CXCL13, CCL8, CCL5, LTB, CCL7, BMPR1A | |
| mmu04062 | Chemokine signaling pathway | 8 | CCL24, CCL2, CXCR5, CXCL5, CXCL13, CCL8, CCL5, CCL7 | ||
| mmu05323 | Rheumatoid arthritis | 6 | CCL2, CXCL5, H2-OB, CCL5, MMP3, LTB | ||
| mmu04640 | Hematopoietic cell lineage | 4 | CD38, CD55, CD19, MS4A1 | ||
| mmu00380 | Tryptophan metabolism | 3 | KYNU, CYP1B1, MAOA | ||
| mmu04662 | B cell receptor signaling pathway | 3 | CD19, CD79B, CD79A | ||
| mmu00120 | Primary bile acid biosynthesis | 2 | CYP7B1, CH25H | ||
Abbreviations: GO: gene ontology; BP: biological process; MF: molecular functioning; CC: cellular component; KEGG pathways: Kyoto Encyclopedia of Genes and Genomes pathways; GTP: guanosine triphosphate.
Figure 3Cholesterol-responsive differentially expressed miRNAs and mRNAs between aged and young macrophages. In young macrophages, 6 miRNAs were differentially expressed in response to (oxLDL) (a) and 8 miRNAs in response to (acLDL) (b). Altogether, only miR-714 was downregulated in response to both acLDL and oxLDL. In aged macrophages, no differentially expressed miRNA was identified in response to oxLDL, and miR-5129 was the only differentially upregulated miRNA in response to acLDL (c). Therefore, miR-714 was the differentially expressed miRNAs between young and aged macrophage's response to cholesterol. With regards to differentially expressed mRNAs, 47 were detected when treated with oxLDL (d) and 39 with acLDL (e) in young macrophages and 25 mRNAs expressed differentially in response to both oxLDL and acLDL (f). In aged macrophages, 30 and 16 mRNAs expressed differentially in response to oxLDL (g) and acLDL (h), respectively, and 13 mRNAs in response to both (i).
Figure 4miRNA-mRNA interactions of cholesterol-responsive difference between aged and young macrophages. miRNA-mRNA interaction identification was conducted on cholesterol-responsive differentially expressed miRNAs and mRNAs between aged and young macrophages, and 6 predicted pairs were identified.
Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of the differentially expressed miRNAs targets in response to cholesterol between aged and young macrophages.
| Category | GO term | Description | Count | Genes |
|---|---|---|---|---|
| BP | GO:0006629 | Lipid metabolic process | 5 | Stard4, Fdft1, Hsd17b7, Fasn, Acat2 |
| GO:0044255 | Cellular lipid metabolic process | 4 | Stard4, Fdft1, Fasn, Acat2 | |
| GO:0044281 | Small molecule metabolic process | 4 | Fdft1, Hsd17b7, Fasn, Acat2 | |
| GO:0008202 | Steroid metabolic process | 3 | Stard4, Fdft1, Hsd17b7 | |
| GO:0008610 | Lipid biosynthetic process | 3 | Fdft1, Hsd17b7, Fasn | |
| GO:0044283 | Small molecule biosynthetic process | 3 | Fdft1, Hsd17b7, Fasn | |
| GO:0055114 | Oxidation-reduction process | 3 | Hsd17b7, Fasn, Acat2 | |
| GO:0097384 | Cellular lipid biosynthetic process | 2 | Fdft1, Fasn | |
| GO:0006695 | Cholesterol biosynthetic process | 2 | Stard4, Fdft1 | |
| GO:0008203 | Cholesterol metabolic process | 2 | Fdft1, Hsd17b7 | |
| GO:0030258 | Lipid modification | 2 | Stard4, Acat2 | |
| GO:0006631 | Fatty acid metabolic process | 2 | Fasn, Acat2 | |
|
| ||||
| MF | GO:0016407 | Acetyltransferase activity | 2 | Fasn, Acat2 |
| GO:0016616 | Oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2 | Hsd17b7, Fasn | |
|
| ||||
| KEGG pathways | mmu01100 | Metabolic pathways | 4 | Fdft1, Hsd17b7, Fasn, Acat2 |
| mmu01212 | Fatty acid metabolism | 2 | Fasn, Acat2 | |
| mmu00100 | Steroid biosynthesis | 2 | Fdft1, Hsd17b7 | |
Abbreviations: GO: gene ontology; BP: biological process; MF: molecular functioning; KEGG pathways: Kyoto Encyclopedia of Genes and Genomes pathways; NAD: nicotinamide adenine dinucleotide; NADP: nicotinamide adenine dinucleotide phosphate.
Figure 5Protein-protein interaction analysis of age-related miRNA target genes in response to cholesterol and farnesyl diphosphate farnesyl transferase 1 (FDFT1) was identified as the key mRNA.